Literature DB >> 25848491

Respiratory distress due to malignant ascites palliated by hyperthermic intraperitoneal chemotherapy.

Marijn Marinus Leonardus van den Houten1, Thijs Ralf van Oudheusden1, Michael Derek Philip Luyer1, Simon Willem Nienhuijs1, Ignace Hubertus Johannes Theodorus de Hingh1.   

Abstract

Malignant ascites is a common symptom in patients with peritoneal cancer. Current assumption is that an increased vascular permeability and obstruction of lymphatic channels lead to the accumulation of fluid in the abdominal cavity. This case report describes a severely symptomatic patient with malignant ascites. The previously healthy 73-year-old male was presented with abdominal distention causing respiratory distress. Computed tomography revealed large amounts of ascites, a recto-sigmoidal mass with locoregional lymphadenopathy and an omental cake. Biopsy taken during colonoscopy revealed an adenocarcinoma of the colon with signet cell differentiation. A widespread peritoneal carcinomatosis was found during a diagnostic laparoscopy. The extent of peritoneal disease rendered the patient not suitable for cytoreductive surgery with curative intent. The ascites proved to be refractory to ultrasound-guided paracentesis; thus, a decision was made to perform palliative hyperthermic intraperitoneal chemotherapy without cytoreductive surgery. Consequently, ascites production stopped, and the respiratory distress was relieved thereafter. The postoperative recovery was uneventful. Ascites recurred eight months later, and a second hyperthermic intraperitoneal chemotherapy procedure was performed. The patient was still alive at the time of writing, 16 mo after the initial diagnosis.

Entities:  

Keywords:  Ascites; Colorectal cancer; Intraperitoneal chemotherapy; Palliative hyperthermic intraperitoneal chemotherapy; Peritoneal carcinomatosis

Year:  2015        PMID: 25848491      PMCID: PMC4381155          DOI: 10.4240/wjgs.v7.i3.39

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  14 in total

1.  Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites.

Authors:  A Garofalo; M Valle; J Garcia; P H Sugarbaker
Journal:  Eur J Surg Oncol       Date:  2006-04-21       Impact factor: 4.424

2.  Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.

Authors:  Suma L Sangisetty; Thomas J Miner
Journal:  World J Gastrointest Surg       Date:  2012-04-27

Review 3.  Malignant ascites: systematic review and guideline for treatment.

Authors:  Gerhild Becker; Daniel Galandi; Hubert E Blum
Journal:  Eur J Cancer       Date:  2006-01-24       Impact factor: 9.162

4.  Pattern and prognostic factors in patients with malignant ascites: a retrospective study.

Authors:  A A Ayantunde; S L Parsons
Journal:  Ann Oncol       Date:  2007-02-13       Impact factor: 32.976

Review 5.  Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited.

Authors:  J T Tamsma; H J Keizer; A E Meinders
Journal:  Ann Oncol       Date:  2001-10       Impact factor: 32.976

6.  Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi-institutional retrospective analysis in 52 patients.

Authors:  M Valle; K Van der Speeten; A Garofalo
Journal:  J Surg Oncol       Date:  2009-09-15       Impact factor: 3.454

7.  Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics.

Authors:  P J Pockros; K T Esrason; C Nguyen; J Duque; S Woods
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

8.  Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites.

Authors:  Reese W Randle; Katrina R Swett; Douglas S Swords; Perry Shen; John H Stewart; Edward A Levine; Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2013-08-28       Impact factor: 5.344

9.  Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.

Authors:  E Facchiano; S Scaringi; R Kianmanesh; J M Sabate; B Castel; Y Flamant; B Coffin; S Msika
Journal:  Eur J Surg Oncol       Date:  2007-07-20       Impact factor: 4.424

10.  Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options.

Authors:  Yvonne L B Klaver; Valery E P P Lemmens; Simon W Nienhuijs; Misha D P Luyer; Ignace H J T de Hingh
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.